Immunotherapy and targeted therapy of advanced melanoma: Treatment benefits and cost in an unselected real-life population
Project
|Updated
Project leader
Bettina Kulle Andreassen, The Cancer Registry of Norway, Norwegian Institute of Public Health
Project participants
Denise Reis Costa, The Cancer Registry of Norway, Norwegian Institute of Public Health
Giske Ursin, The Cancer Registry of Norway, Norwegian Institute of Public Health
Start
01.07.2021
End
31.12.2025
Status
Active
Project owner/ Project manager
Norwegian Institute of Public Health